Allen Poirson Cytek Biosciences, Inc. (CTKB) insider trading activity

Allen Poirson is SVP BUS. AND CORP. DEV. of Cytek Biosciences, Inc.. Currently has a direct ownership of 56,825 shares of CTKB, which is worth approximately $290,375. The most recent transaction as insider was on Aug 19, 2024, when has been sold 2,015 shares (Common Stock) at a price of $5.53 per share, resulting in proceeds of $11,142. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 56.8K

5.88% 3M change

22.14% 12M change

Total Value Held $290,375

Allen Poirson Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 19 2024	SELL Payment of exercise price or tax liability	$11,142 $5.53 p/Share	2,015 Reduced 3.42%	56,825 Common Stock
Aug 19 2024	BUY Exercise of conversion of derivative security	-	5,171 Added 8.24%	57,557 Common Stock
May 20 2024	SELL Payment of exercise price or tax liability	$8,624 $5.96 p/Share	1,447 Reduced 2.63%	53,669 Common Stock
May 20 2024	BUY Exercise of conversion of derivative security	-	3,711 Added 6.41%	54,157 Common Stock
Mar 11 2024	SELL Payment of exercise price or tax liability	$9,393 $7.22 p/Share	1,301 Reduced 2.48%	51,055 Common Stock
Mar 11 2024	BUY Exercise of conversion of derivative security	-	3,338 Added 5.99%	52,356 Common Stock
Feb 20 2024	SELL Payment of exercise price or tax liability	$2,581 $8.38 p/Share	308 Reduced 0.62%	49,018 Common Stock
Feb 20 2024	BUY Exercise of conversion of derivative security	-	790 Added 1.58%	49,326 Common Stock
Nov 18 2023	SELL Payment of exercise price or tax liability	$7,672 $5.98 p/Share	1,283 Reduced 2.58%	48,536 Common Stock
Nov 18 2023	BUY Exercise of conversion of derivative security	-	3,293 Added 6.24%	49,511 Common Stock
Aug 18 2023	SELL Payment of exercise price or tax liability	$10,854 $8.46 p/Share	1,283 Reduced 2.68%	46,526 Common Stock
Aug 18 2023	BUY Exercise of conversion of derivative security	-	3,293 Added 6.48%	47,501 Common Stock
May 18 2023	SELL Payment of exercise price or tax liability	$6,415 $6.69 p/Share	959 Reduced 2.12%	44,208 Common Stock
May 18 2023	BUY Exercise of conversion of derivative security	-	2,459 Added 5.2%	44,859 Common Stock
Feb 21 2023	SELL Payment of exercise price or tax liability	$3,378 $10.97 p/Share	308 Reduced 0.72%	42,708 Common Stock
Feb 21 2023	BUY Exercise of conversion of derivative security	-	790 Added 1.8%	43,016 Common Stock
Nov 18 2022	SELL Payment of exercise price or tax liability	$4,543 $14.75 p/Share	308 Reduced 0.73%	41,989 Common Stock
Nov 18 2022	BUY Exercise of conversion of derivative security	-	790 Added 1.83%	42,297 Common Stock
Aug 18 2022	SELL Payment of exercise price or tax liability	$4,330 $14.06 p/Share	308 Reduced 0.74%	41,507 Common Stock
Aug 18 2022	BUY Exercise of conversion of derivative security	-	790 Added 1.85%	41,815 Common Stock
May 18 2022	SELL Payment of exercise price or tax liability	$3,966 $9.65 p/Share	411 Reduced 0.99%	41,025 Common Stock
May 18 2022	BUY Exercise of conversion of derivative security	-	1,053 Added 2.48%	41,436 Common Stock
Jul 22 2021	BUY Open market or private purchase	$25,500 $17.0 p/Share	1,500 Added 3.58%	40,383 Common Stock

Allen Poirson

SVP BUS. AND CORP. DEV.

Fremont, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CTKB shares.

Notify only if

Value

Insider Trading

Get notified when an Cytek Biosciences, Inc. insider buys or sells CTKB shares.

Notify only if

Operation

Value

Type

News

Receive news related to Cytek Biosciences, Inc.

Track Activities on CTKB

Account